\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits
Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...
\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits
Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...
Progress
44% Bias Score
Sackler Family Agrees to $7.4 Billion Opioid Settlement
The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.
Sackler Family Agrees to $7.4 Billion Opioid Settlement
The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.
Progress
40% Bias Score
McKinsey to Pay $650 Million in Opioid Crisis Settlement
McKinsey & Company will pay $650 million to settle criminal charges for conspiring with Purdue Pharma to misbrand OxyContin, contributing to the US opioid crisis which resulted in nearly 100,000 overdose deaths annually, though recently decreased by 14%.
McKinsey to Pay $650 Million in Opioid Crisis Settlement
McKinsey & Company will pay $650 million to settle criminal charges for conspiring with Purdue Pharma to misbrand OxyContin, contributing to the US opioid crisis which resulted in nearly 100,000 overdose deaths annually, though recently decreased by 14%.
Progress
44% Bias Score
McKinsey to Pay $650 Million in Opioid Settlement
McKinsey & Company agreed to pay $650 million to settle federal charges for its role in boosting OxyContin sales, including $2 million to Virginia's Medicaid Fraud Control Unit; a former partner pleaded guilty to obstruction of justice.
McKinsey to Pay $650 Million in Opioid Settlement
McKinsey & Company agreed to pay $650 million to settle federal charges for its role in boosting OxyContin sales, including $2 million to Virginia's Medicaid Fraud Control Unit; a former partner pleaded guilty to obstruction of justice.
Progress
52% Bias Score
Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement
Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...
Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement
Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...
Progress
48% Bias Score
Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion
Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.
Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion
Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.
Progress
36% Bias Score
McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.
McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.
Progress
36% Bias Score